TARDBP and amyotrophic lateral sclerosis: Cultures with MNs derived from ALS-hiPSCs carrying a TDP-43 mutation evidenced weaker contractions, reduced axonal growth and reduced numbers of neuromuscular synapses and also demonstrated the use of this system as a platform to test the effect of candidate drugs [209].